Literature DB >> 30111624

Oligomerization and Catalytic Parameters of Human UDP-Glucuronosyltransferase 1A10: Expression and Characterization of the Recombinant Protein.

Kyungbo Kim1, Fang Zheng1, Chang-Guo Zhan2.   

Abstract

UDP-glucuronosyltransferase (UGT), as an integral membrane protein localized in the endoplasmic reticulum, has the ability to detoxify potentially hazardous xenobiotic substances. Most UGTs are expressed in liver, but UGT1A10 has proven to be an extrahepatic enzyme considerably expressed throughout the gastrointestinal tract. Earlier studies indicated that different UGT isoforms could exist in higher-order homo-oligomers or at least dimers within the membrane, but the formation of intermolecular disulfide bridges between UGT molecules was not often observed. In this study, we expressed recombinant human UGT1A10 in human embryonic kidney (HEK)293 and Chinese hamster ovary (CHO) cells to examine its oligomeric states and characterize its enzymatic activities against two therapeutically interesting substrates, morphine and entacapone, including determination of the catalytic rate constant (kcat) values for the first time. It was observed that a majority of the UGT1A10 protein expressed in HEK293 cells existed in covalently crosslinked higher-order oligomers via formation of intermolecular disulfide bonds, whereas formation of the intermolecular disulfide bonds was not observed in the UGT1A10 protein expressed in CHO cells. Owing to the formation of the covalently crosslinked higher-order oligomers, the UGT1A10 protein expressed in HEK293 cells had much lower catalytic activity (particularly the catalytic rate constant kcat) against both morphine and entacapone, compared with the UGT1A10 protein form expressed in CHO cells against the same substrates.
Copyright © 2018 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30111624      PMCID: PMC6130470          DOI: 10.1124/dmd.118.082495

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  23 in total

Review 1.  The UDP-glucuronosyltransferases as oligomeric enzymes.

Authors:  Moshe Finel; Mika Kurkela
Journal:  Curr Drug Metab       Date:  2008-01       Impact factor: 3.731

Review 2.  Structure and function of uridine diphosphate glucuronosyltransferases.

Authors:  R Meech; P I Mackenzie
Journal:  Clin Exp Pharmacol Physiol       Date:  1997-12       Impact factor: 2.557

3.  Expression and characterization of recombinant human UDP-glucuronosyltransferases (UGTs). UGT1A9 is more resistant to detergent inhibition than other UGTs and was purified as an active dimeric enzyme.

Authors:  Mika Kurkela; J Arturo García-Horsman; Leena Luukkanen; Saila Mörsky; Jyrki Taskinen; Marc Baumann; Risto Kostiainen; Jouni Hirvonen; Moshe Finel
Journal:  J Biol Chem       Date:  2002-11-14       Impact factor: 5.157

Review 4.  Oral morphine for cancer pain.

Authors:  Philip J Wiffen; Bee Wee; R Andrew Moore
Journal:  Cochrane Database Syst Rev       Date:  2013-07-22

Review 5.  Morphine metabolites.

Authors:  L L Christrup
Journal:  Acta Anaesthesiol Scand       Date:  1997-01       Impact factor: 2.105

Review 6.  A historical overview of the heterologous expression of mammalian UDP-glucuronosyltransferase isoforms over the past twenty years.

Authors:  Anna Radominska-Pandya; Stacie Bratton; Joanna M Little
Journal:  Curr Drug Metab       Date:  2005-04       Impact factor: 3.731

7.  Human UDP-glucuronosyltransferase (UGT) 2B10 in drug N-glucuronidation: substrate screening and comparison with UGT1A3 and UGT1A4.

Authors:  Yukiko Kato; Takeshi Izukawa; Shingo Oda; Tatsuki Fukami; Moshe Finel; Tsuyoshi Yokoi; Miki Nakajima
Journal:  Drug Metab Dispos       Date:  2013-04-23       Impact factor: 3.922

8.  Glucuronidation of oxidized fatty acids and prostaglandins B1 and E2 by human hepatic and recombinant UDP-glucuronosyltransferases.

Authors:  Joanna M Little; Mika Kurkela; Julia Sonka; Sirkku Jäntti; Raimo Ketola; Stacie Bratton; Moshe Finel; Anna Radominska-Pandya
Journal:  J Lipid Res       Date:  2004-07-01       Impact factor: 5.922

9.  Interactions between human UGT1A1, UGT1A4, and UGT1A6 affect their enzymatic activities.

Authors:  Ryoichi Fujiwara; Miki Nakajima; Hiroyuki Yamanaka; Miki Katoh; Tsuyoshi Yokoi
Journal:  Drug Metab Dispos       Date:  2007-07-09       Impact factor: 3.922

10.  Preparation and in vivo characterization of a cocaine hydrolase engineered from human butyrylcholinesterase for metabolizing cocaine.

Authors:  Liu Xue; Shurong Hou; Min Tong; Lei Fang; Xiabin Chen; Zhenyu Jin; Hsin-Hsiung Tai; Fang Zheng; Chang-Guo Zhan
Journal:  Biochem J       Date:  2013-08-01       Impact factor: 3.857

View more
  2 in total

1.  Alternative transcript splicing regulates UDP-glucosyltransferase-catalyzed detoxification of DIMBOA in the fall armyworm (Spodoptera frugiperda).

Authors:  Bhawana Israni; Katrin Luck; Samantha C W Römhild; Bettina Raguschke; Natalie Wielsch; Yvonne Hupfer; Michael Reichelt; Aleš Svatoš; Jonathan Gershenzon; Daniel Giddings Vassão
Journal:  Sci Rep       Date:  2022-06-20       Impact factor: 4.996

2.  Integrate thermostabilized fusion protein apocytochrome b 562 RIL and N-glycosylation mutations: A novel approach to heterologous expression of human UDP-glucuronosyltransferase (UGT) 2B7.

Authors:  Jia Xue; Haitao Zhang; Su Zeng
Journal:  Front Pharmacol       Date:  2022-08-12       Impact factor: 5.988

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.